id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-N-3818-0197,FDA,FDA-2016-N-3818,Reference 86 Content and Format of Substantial Equivalence Reports Final Rule Final Regulatory Impact Analysis re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-07T04:00:00Z,2021,10,,,2021-10-07T20:20:44Z,,0,0,0900006484dbe831
FDA-2016-N-3818-0196,FDA,FDA-2016-N-3818,Reference 67 Assessment-of-Hazards to Occupants from Smoke 2016 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-06T04:00:00Z,2021,10,,,2021-10-06T12:09:11Z,,0,0,0900006484dbb620
FDA-2016-N-3818-0178,FDA,FDA-2016-N-3818,Reference 15 Cigarette Yields and Human Exposure-A Comparison...Testing Regimens 2006 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:36:49Z,,0,0,0900006484dbae90
FDA-2016-N-3818-0188,FDA,FDA-2016-N-3818,FRIA Ref 3 FDA Report to House Committee on Appropriations 2018 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:03:45Z,,0,0,0900006484dba8da
FDA-2016-N-3818-0176,FDA,FDA-2016-N-3818,Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Rule,Final Rule,2021-10-05T04:00:00Z,2021,10,2021-10-05T04:00:00Z,,2021-10-05T20:23:28Z,2021-21009,0,0,0900006484dba96e
FDA-2016-N-3818-0180,FDA,FDA-2016-N-3818,Reference 27. ISO 3308-2012. Routine analytical cigarette-smoking machine - Definitions and standard conditions re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:40:46Z,,0,0,0900006484dbaeaa
FDA-2016-N-3818-0195,FDA,FDA-2016-N-3818,Reference 79 Nitrate Concentration Changes During Senescence and Air Curing of Burley Tobacco 1982 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:14:47Z,,0,0,0900006484dba8ae
FDA-2016-N-3818-0191,FDA,FDA-2016-N-3818,FRIA Ref 6a May 2018 OES Wage Estimates - NAICS 312000 Beverage and Tobacco Product Manufacturing re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:07:56Z,,0,0,0900006484dbb12e
FDA-2016-N-3818-0182,FDA,FDA-2016-N-3818,Reference 31 In Vitro Study of Nicotine Release from Smokeless Tobacco 1998 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:44:15Z,,0,0,0900006484dbae93
FDA-2016-N-3818-0187,FDA,FDA-2016-N-3818,FRIA Ref 2 84 FR 12740 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:57:17Z,,0,0,0900006484dbae71
FDA-2016-N-3818-0190,FDA,FDA-2016-N-3818,FRIA Ref 5 Memo_SEApril5 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:06:17Z,,0,0,0900006484dbb12d
FDA-2016-N-3818-0185,FDA,FDA-2016-N-3818,SE FRIA References List - re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:54:56Z,,0,0,0900006484dbae6a
FDA-2016-N-3818-0186,FDA,FDA-2016-N-3818,FRIA Ref 1 SE PRIA re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:56:14Z,,0,0,0900006484dba8d8
FDA-2016-N-3818-0184,FDA,FDA-2016-N-3818,Reference 43 Lower Ignition Propensity re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:50:11Z,,0,0,0900006484dbaead
FDA-2016-N-3818-0194,FDA,FDA-2016-N-3818,FRIA Ref 8 us 6digitnaics 2012 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:10:49Z,,0,0,0900006484dbaeab
FDA-2016-N-3818-0189,FDA,FDA-2016-N-3818,FRIA Ref 4 FDA Report to House Committee on Appropriations 2019 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:05:18Z,,0,0,0900006484dbb12c
FDA-2016-N-3818-0177,FDA,FDA-2016-N-3818,Reference List - Substantial Equivalence Final Rule re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:32:58Z,,0,0,0900006484dbae54
FDA-2016-N-3818-0179,FDA,FDA-2016-N-3818,Reference 16  Physical Design Analysis and Mainstream Smoke Constituent Yields 2007 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:37:49Z,,0,0,0900006484dbb135
FDA-2016-N-3818-0181,FDA,FDA-2016-N-3818,Reference 29 The Health Consequences of Smoking-The Changing Cigarette 1981 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:43:01Z,,0,0,0900006484dbae92
FDA-2016-N-3818-0183,FDA,FDA-2016-N-3818,Reference 33 The Role of Filter Technology in Reduced Yield Cigarettes 2004 re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T19:46:57Z,,0,0,0900006484dbaeac
FDA-2016-N-3818-0192,FDA,FDA-2016-N-3818,FRIA Ref 6b May 2018 OES Wage Estimates - NAICS 312200 Tobacco Manufacturing re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:09:01Z,,0,0,0900006484dbb130
FDA-2016-N-3818-0193,FDA,FDA-2016-N-3818,FRIA Ref 7 SBA Table of Size Standards Effective Aug 19 2019 Rev re: Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports,Supporting & Related Material,Background Material,2021-10-05T04:00:00Z,2021,10,,,2021-10-05T20:09:45Z,,0,0,0900006484dbae8c